Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 75,081 | 71,359 | 64,779 | 55,557 | 40,136 |
| Cost of Goods | 22,765 | 28,989 | 26,784 | 23,827 | 13,670 |
| Gross Profit | 52,316 | 42,370 | 37,995 | 31,730 | 26,466 |
| Operating Expenses | 20,474 | 23,643 | 24,811 | 25,019 | 21,549 |
| Operating Income | 32,607 | 19,715 | 13,967 | 7,538 | 5,587 |
| Other Income | -127 | -188 | -182 | -195 | -74 |
| Pre-tax Income | 32,480 | 19,527 | 13,785 | 7,343 | 5,512 |
| Income Tax | 11,905 | 7,770 | 5,318 | 3,027 | 1,825 |
| Net Income Continuous | 20,575 | 11,758 | 8,467 | 4,316 | 3,688 |
| Net Income | $20,575 | $11,758 | $8,467 | $4,316 | $3,688 |
| EPS Basic Total Ops | 1.46 | 0.89 | 0.65 | 0.34 | 0.32 |
| EPS Basic Continuous Ops | 1.46 | 0.89 | 0.65 | 0.34 | 0.32 |
| EPS Diluted Total Ops | 1.39 | 0.82 | 0.62 | 0.32 | 0.32 |
| EPS Diluted Continuous Ops | 1.39 | 0.82 | 0.62 | 0.32 | 0.32 |
| EBITDA(a) | $37,379 | $24,241 | $17,970 | $10,858 | $6,880 |